Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$46.55 USD
-0.83 (-1.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $46.57 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.05 |
EPS Last Quarter | -1.69 |
Last EPS Surprise | -6.96% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.85 |
Next Year | -6.52 |
EPS (TTM) | -6.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.38M | 10.53M | 36.72M | 64.44M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 9.70M | 11.16M | 37.59M | 71.98M |
Low Estimate | 8.81M | 9.31M | 34.93M | 58.41M |
Year ago Sales | 7.40M | 7.10M | 26.82M | 36.72M |
Year over Year Growth Est. | 26.78% | 48.27% | 36.89% | 75.51% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.05 | -1.79 | -4.85 | -6.52 |
# of Estimates | 4 | 3 | 4 | 6 |
Most Recent Consensus | 1.78 | -1.72 | -3.08 | -6.75 |
High Estimate | 1.81 | -1.68 | -3.00 | -5.82 |
Low Estimate | -1.71 | -1.96 | -6.78 | -7.43 |
Year ago EPS | -1.64 | -1.72 | -6.33 | -4.85 |
Year over Year Growth Est. | 103.05% | -4.07% | 23.38% | -34.42% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 0 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 3 | 1 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.05 | -1.79 | -4.85 | -6.52 |
7 Days Ago | 0.05 | -1.79 | -4.85 | -6.52 |
30 Days Ago | 0.05 | -1.79 | -4.85 | -6.48 |
60 Days Ago | -1.48 | -1.56 | -6.25 | -5.73 |
90 Days Ago | -1.48 | -1.56 | -6.25 | -5.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.05 | -1.79 | -4.85 | -6.75 |
Zacks Consensus Estimate | 0.05 | -1.79 | -4.85 | -6.52 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -3.58% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.69 | -1.45 | -1.72 | -1.64 | NA |
Estimate | -1.58 | -1.64 | -1.64 | -1.69 | NA |
Difference | -0.11 | 0.19 | -0.08 | 0.05 | 0.01 |
Surprise | -6.96% | 11.59% | -4.88% | 2.96% | 0.68% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more